At the last check on Thursday, Cue Health Inc.’s (NASDAQ:HLTH) stock was up $0.07, moving up 15.62 percent to $0.51. The average number of shares traded per day over the past five days has been 627,806 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0246 fall in that time frame. In the last twenty days, the average volume was 648,717, while in the previous 50 days, it was 889,727.
Since last month, HLTH stock rose 13.43%. Shares of the company fell to $0.3100 on 08/16/23, the lowest level in the past month. A 52-week high of $4.38 was reached on 02/03/23 after having rallying from a 52-week low of $0.31. Since the beginning of this year, HLTH’s stock price has dropped by -75.36% or -$1.5534, and marked a new high 9 times. However, the stock has declined by -88.35% since its 52-week high.
HLTH stock investors should be aware that Cue Health Inc. (HLTH) stock had its last reported insider trading activity 266 days ago on Dec 08. Sever Clint, the Chief Product Officer of the company, disposed of 29,269 shares for $3.02 on Dec 08. It resulted in a $88,334 divestment by the insider. Sever Clint sold 24,147 shares at an average price of $2.98 on Dec 07. The insider now owns 3,939,647 shares following the transaction. On Dec 06, Chief Product Officer Sever Clint sold 26,664 shares at $3.14 apiece. The transaction was valued at $83,725.
Valuation Metrics
The stock’s beta is 1.05. Besides these, the trailing price-to-sales (P/S) ratio of 0.38, the price-to-book (PB) ratio of 0.18.
Financial Health
In the three months ended June 29, Cue Health Inc.’s quick ratio stood at 2.50, while its current ratio was 3.70, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 16.10% percent. Based on annual data, HLTH earned $153.5 million in gross profit and brought in $483.48 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -33.80%. Return on equity (ROE) for the past 12 months was -52.90%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. HLTH’s revenue fell -785.86% to $24.77 million during the quarter, while net income inched up to $9.9 million. While analysts expected Cue Health Inc. to report -$0.5 quarterly earnings, the actual figure was -$0.55 per share. During the quarter, the company generated -$73.04 million in EBITDA. The liabilities of Cue Health Inc. were 100.68 million at the end of its most recent quarter ended June 29, and its total debt was $51.08 million. The value of shareholders’ equity is $153.51 million.
Technical Picture
This quick technical analysis looks at Cue Health Inc.’s (HLTH) price momentum. With a historical volatility rate of 210.01%, the RSI 9-day stood at 65.13% on 30 August.
With respect to its five-day moving average, the current Cue Health Inc. price is down by -4.55% percent or -$0.0246. At present, HLTH shares trade +8.28% above its 20-day simple moving average and -72.52% percent below its 100-day simple moving average. However, the stock is currently trading approximately +16.69% above its SMA50 and -85.41% below its SMA200.
Stochastic coefficient K was 54.16% and Stochastic coefficient D was 47.10%, while ATR was 0.0667. Given the Stochastic reading of 72.24% for the 14-day period, the RSI (14) reading has been calculated as 60.60%. As of today, the MACD Oscillator reading stands at 0.0213, while the 14-day reading stands at 0.0529.
Analyst Ratings
Cue Health Inc. (HLTH) has been rated Overweight by analysts. According to 0 brokerage firms, HLTH is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Cue Health Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $2.00, the current consensus forecast for the stock is $0.75 – $8.00. Based on these forecasts, analysts predict Cue Health Inc. (HLTH) will achieve an average price target of $3.58.
